Skip to main content
SleepCited

Kava لـ الأرق

A

Based on 34 studies (8 meta-analyses, 1 RCT) with 4,679 total participants. Results are mixed across studies.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dkava\u0026condition\u003Dinsomnia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

الخلاصة

Based on 34 studies (8 meta-analyses, 1 RCT) with 4,679 total participants. Results are mixed across studies.

Key Study Findings

Case Reports n=1 6 weeks
Diagnosing Acute Kava Dermopathy: A Case Report of a Characteristic Cutaneous Eruption.
Dose: None مقابل: None Outcome: acute kava dermopathy with sebaceous gland necrosis التأثير: None None

المجتمع المدروس: 41-year-old Australian woman consuming kava for anxiety and insomnia

Review
Integrative sleep management: from molecular pathways to conventional and herbal treatments.
Dose: None مقابل: Placebo التأثير: None None
Case Reports n=1 Open-label
Severe kava withdrawal managed with phenobarbital.
Dose: None مقابل: None Outcome: Resolution of kava withdrawal symptoms التأثير: None None

المجتمع المدروس: 45-year-old man with kava and kratom withdrawal

narrative review
Herbal and Natural Supplements for Improving Sleep: A Literature Review.
Dose: varies by supplement مقابل: Placebo التأثير: None None
Other Double-blind
The potential of AB-free kava in enabling tobacco cessation via management of abstinence-related stress and …
Dose: AB-free kava extract مقابل: Placebo Outcome: Tobacco cessation via stress/insomnia management التأثير: None None

المجتمع المدروس: Adult smokers (trial protocol)

Key Statistics

34

الدراسات

4679

المشاركون

Mixed

A

التقييم

Referenced Papers

Naunyn-Schmiedeberg's archives of … 2025 4 اقتباسات
The American journal … 2025 1 اقتباسات
Psychiatry investigation 2024 24 اقتباسات
Pharmacological research 2022 51 اقتباسات
Journal of clinical … 2022 27 اقتباسات
Journal of psychosocial … 2022 2 اقتباسات
Combinatorial chemistry & … 2021 16 اقتباسات
Chemical research in … 2019 6 اقتباسات
Phytotherapy research : … 2018 95 اقتباسات
Journal of medicinal … 2018 19 اقتباسات
Sleep medicine reviews 2015 152 اقتباسات
Advances in pharmacological … 2011 79 اقتباسات
Journal of psychopharmacology … 2005 176 اقتباسات
Integrative cancer therapies 2004 59 اقتباسات
Human psychopharmacology 2003 45 اقتباسات
Primary care 2002 43 اقتباسات
Phytotherapy research : … 2001 74 اقتباسات
Human psychopharmacology 2001 52 اقتباسات
Psychosomatic medicine 1999 136 اقتباسات
Der Hautarzt; Zeitschrift … 1996 22 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

sleep:
120-250 mg kavalactones/day, 1-2 hrs before bed

الحد الأعلى: 250 mg kavalactones/day (European guidelines); limited to 3 months continuous use

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
None 6 weeks Negative 1
None -- Positive --
None -- Positive 1
varies by supplement -- Positive --
AB-free kava extract -- Mixed --
various -- Mixed 17
None -- Mixed --
Various medicinal herbs: Silexan, Kava, Ginkgo biloba, Withania somnifera, Galphimia glauca, Passion -- Positive --

أفضل وقت للتناول: 1-2 hours before bed; avoid daily use beyond 3 months without medical supervision

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Drowsiness and reduced coordination
  • Hepatotoxicity (rare but serious — consult healthcare provider)
  • Skin rash (kava dermopathy) with chronic high-dose use
  • GI discomfort

التفاعلات المعروفة

  • Alcohol — increased hepatotoxicity risk and CNS depression
  • Hepatotoxic medications (acetaminophen, statins) — additive liver stress
  • Benzodiazepines and sedatives — additive CNS depression
  • CYP450 substrates (2E1, 1A2, 2D6) — kavalactones may inhibit metabolism
  • Levodopa and dopaminergic drugs — kava may reduce efficacy

الحد الأقصى المسموح به: 250 mg kavalactones/day (European guidelines); limited to 3 months continuous use

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does Kava help with الأرق?
Based on 34 studies with 4,679 participants, there is strong evidence from multiple clinical trials that Kava may support الأرق management. Our evidence grade is A (Strong Evidence).
How much Kava should I take for الأرق?
Studies have used various dosages. A commonly studied range is 120-250 mg kavalactones/day, 1-2 hrs before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Kava?
Reported side effects may include Drowsiness and reduced coordination, Hepatotoxicity (rare but serious — consult healthcare provider), Skin rash (kava dermopathy) with chronic high-dose use, GI discomfort. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Kava and الأرق?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 34 peer-reviewed studies with 4,679 total participants. The overall direction of effect is mixed.

Related Evidence

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.